Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 10, 2016, Pages 1433-1438

  Khoruts, Alexander ^a,b   Rank, Kevin M ^a   Newman, Krista M ^a   Viskocil, Kimberly ^a   Vaughn, Byron P ^a   Hamilton, Matthew J ^b   Sadowsky, Michael J ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Clostridium Difficile; Complication; Crohn's Disease; Ulcerative Colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; COLLAGENOUS COLITIS; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; DISEASE EXACERBATION; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RELAPSE; RISK FACTOR; SEX RATIO; SYMPTOM; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; CLOSTRIDIUM INFECTIONS; COMPLICATION; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MINNESOTA; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SECONDARY PREVENTION; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MINNESOTA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84964765013     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2016.02.018     Document Type: Article

References (15)

1. 1 Khoruts, A., Sadowsky, M.J., Hamilton, MJ., Development of fecal microbiota transplantation suitable for mainstream medicine. Clin Gastroenterol Hepatol 13 (2015), 246–250.
2. 2 Hamilton, M.J., Weingarden, A.R., Unno, T., et al. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 4 (2013), 125–135.
3. 3 van Nood, E., Vrieze, A., Nieuwdorp, M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368 (2013), 407–415.
4. 4 Weingarden, A., Gonzalez, A., Vazquez-Baeza, Y., et al. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome, 3, 2015, 10.
5. 5 Kostic, A.D., Xavier, R.J., Gevers, D., The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146 (2014), 1489–1499.
6. 6 Ananthakrishnan, A.N., Detecting and treating Clostridium difficile infections in patients with inflammatory bowel disease. Gastroenterol Clin North Am 41 (2012), 339–353.
7. 7 Tong, J., Zheng, Q., Zhang, C., et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol 110 (2015), 265–276 quiz 277.
8. 8 Agrawal, M., Aroniadis, O.C., Brandt, L.J., et al. The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals. J Clin Gastroenterol 50 (2016), 403–407.
9. 9 Hamilton, M.J., Weingarden, A.R., Sadowsky, M.J., et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107 (2012), 761–767.
10. 10 Weingarden, A.R., Chen, C., Bobr, A., et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 306 (2014), G310–319.
11. 11 Giesemann, T., Guttenberg, G., Aktories, K., Human alpha-defensins inhibit Clostridium difficile toxin B. Gastroenterology 134 (2008), 2049–2058.
12. 12 Wehkamp, J., Salzman, N.H., Porter, E., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102 (2005), 18129–18134.
13. 13 Nitzan, O., Elias, M., Chazan, B., et al. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol 19 (2013), 7577–7585.
14. 14 Schwartz, D., Lellouch, J., Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20 (1967), 637–648.
15. 15 Patsopoulos, N.A., A pragmatic view on pragmatic trials. Dialogues Clin Neurosci 13 (2011), 217–224.